Mickael Löthgren

2.9k total citations
68 papers, 1.9k citations indexed

About

Mickael Löthgren is a scholar working on Economics and Econometrics, Management Science and Operations Research and Surgery. According to data from OpenAlex, Mickael Löthgren has authored 68 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Economics and Econometrics, 11 papers in Management Science and Operations Research and 10 papers in Surgery. Recurrent topics in Mickael Löthgren's work include Health Systems, Economic Evaluations, Quality of Life (20 papers), Efficiency Analysis Using DEA (11 papers) and Lipoproteins and Cardiovascular Health (8 papers). Mickael Löthgren is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (20 papers), Efficiency Analysis Using DEA (11 papers) and Lipoproteins and Cardiovascular Health (8 papers). Mickael Löthgren collaborates with scholars based in Switzerland, United States and Sweden. Mickael Löthgren's co-authors include Ulf‐G. Gerdtham, Johan Lyhagen, Rolf Larsson, Magnus Tambour, Sune Karlsson, Peter Lindgren, Gregg C. Fonarow, Sibilia Quilici, A Garcia-Cebrian and J Chancellor and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Mickael Löthgren

63 papers receiving 1.7k citations

Peers

Mickael Löthgren
Joseph V. Terza United States
Son Nghiem Australia
Keisuke Hirano Japan
Federico Belotti Italy
Heinz Zimmermann Switzerland
Robert J. Reynolds United States
James M. Griffin United States
Linh Pham United States
Vincenzo Atella Italy
Klaus Prettner Austria
Joseph V. Terza United States
Mickael Löthgren
Citations per year, relative to Mickael Löthgren Mickael Löthgren (= 1×) peers Joseph V. Terza

Countries citing papers authored by Mickael Löthgren

Since Specialization
Citations

This map shows the geographic impact of Mickael Löthgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mickael Löthgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mickael Löthgren more than expected).

Fields of papers citing papers by Mickael Löthgren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mickael Löthgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mickael Löthgren. The network helps show where Mickael Löthgren may publish in the future.

Co-authorship network of co-authors of Mickael Löthgren

This figure shows the co-authorship network connecting the top 25 collaborators of Mickael Löthgren. A scholar is included among the top collaborators of Mickael Löthgren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mickael Löthgren. Mickael Löthgren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Steuten, Lotte, et al.. (2024). Proposal for a General Outcome-Based Value Attribution Framework for Combination Therapies. Value in Health. 28(1). 81–87. 1 indexed citations
2.
Towse, Adrian, Mickael Löthgren, Lotte Steuten, & Andrew W. Bruce. (2022). Why We Need a New Outcomes-Based Value Attribution Framework for Combination Regimens in Oncology. Value in Health. 25(11). 1821–1827. 5 indexed citations
3.
Pemberton‐Ross, Peter, et al.. (2019). PCV60 BURDEN OF CARDIOVASCULAR DISEASE AND POTENTIAL IMPACT OF PCSK9I IN THE PREVENTION OF CARDIOVASCULAR EVENTS IN SWITZERLAND. Value in Health. 22. S552–S552. 1 indexed citations
4.
Villa, Guillermo, et al.. (2017). Risk Adjustments In Economic Models - What Is Their Impact On Predicted Rates?. Value in Health. 20(9). A753–A754. 1 indexed citations
5.
Journath, Gunilla, Kristina Hambræus, Emil Hagström, Billie Pettersson, & Mickael Löthgren. (2017). Predicted impact of lipid lowering therapy on cardiovascular and economic outcomes of Swedish atherosclerotic cardiovascular disease guideline. BMC Cardiovascular Disorders. 17(1). 224–224. 6 indexed citations
6.
Villa, Guillermo, Mickael Löthgren, Lucie Kutikova, et al.. (2016). Cost-Effectiveness of Evolocumab in Patients with High Cardiovascular Risk in Spain. Value in Health. 19(7). A651–A652. 2 indexed citations
7.
Fonarow, Gregg C., et al.. (2016). Cost-Effectiveness of LDL-C Lowering With Evolocumab In Patients With High Cardiovascular Risk In The United States. Value in Health. 19(3). A3–A3. 54 indexed citations
8.
Matza, Louis S., Katie D. Stewart, Shravanthi R. Gandra, et al.. (2015). Acute and chronic impact of cardiovascular events on health state utilities. BMC Health Services Research. 15(1). 173–173. 51 indexed citations
9.
Darbà, Josep, et al.. (2015). Cost-utility of denosumab for the treatment of postmenopausal osteoporosis in Spain. ClinicoEconomics and Outcomes Research. 7. 105–105. 16 indexed citations
10.
Villa, Guillermo, et al.. (2014). Ldl-C Lowering Efficacy of Evolocumab (Amg 145) Could Reduce Apheresis in Patients At High Risk for Cardiovascular Events in Germany. Value in Health. 17(7). A504–A505. 1 indexed citations
11.
Fenster, Brett E., et al.. (2014). Acute And Chronic Impact Of Cardiovascular Events On Health State Utilities. Value in Health. 17(7). A493–A493. 4 indexed citations
12.
13.
14.
Heeg, Bart, et al.. (2010). Cost Effectiveness of Long-Acting Risperidone in Sweden. Applied Health Economics and Health Policy. 8(5). 327–341. 19 indexed citations
15.
Quilici, Sibilia, J Chancellor, Mickael Löthgren, et al.. (2009). Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain. BMC Neurology. 9(1). 6–6. 155 indexed citations
16.
Thuresson, Per-Olof, et al.. (2008). A Pharmacoeconomic analysis of compliance gains on antipsychotic medications. Applied Health Economics and Health Policy. 6(4). 189–197. 16 indexed citations
17.
Drummond, Michael, et al.. (2007). Do we fully understand the economic value of vaccines?. Vaccine. 25(32). 5945–5957. 57 indexed citations
18.
Gerdtham, Ulf‐G., Mickael Löthgren, Magnus Tambour, & Clas Rehnberg. (1999). Internal markets and health care efficiency: a multiple-output stochastic frontier analysis. Health Economics. 8(2). 151–164. 54 indexed citations
19.
Larsson, Rolf, Johan Lyhagen, & Mickael Löthgren. (1998). Likelihood-Based Cointegration Tests in Heterogeneous Panels. SSRN Electronic Journal. 6 indexed citations
20.
Löthgren, Mickael & Magnus Tambour. (1995). Bootstrapping DEA-based Efficiency Measures and Malmquist Productivity Indices. A Study of Swedish Eye-Care Service Provision. SSRN Electronic Journal. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph V. Terza Breakdown of academic impact, for papers by Son Nghiem Breakdown of academic impact, for papers by Keisuke Hirano Breakdown of academic impact, for papers by Federico Belotti Breakdown of academic impact, for papers by Heinz Zimmermann Breakdown of academic impact, for papers by Robert J. Reynolds Breakdown of academic impact, for papers by James M. Griffin Breakdown of academic impact, for papers by Linh Pham Breakdown of academic impact, for papers by Vincenzo Atella Breakdown of academic impact, for papers by Klaus Prettner
Rankless by CCL
2026